Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity?

A depletion of natural killer (hTK) cells seems to play a role in the cours e of systemic lupus erythematosus (SLE) whereas the possible involvement in this disease of T cell receptor (TCR) gamma/delta positive T cells is stil l debated. The aim of this study was to evaluate the peripheral blood mononuclear cell s (PBMCs) that express NK surface markers CD16 and CD56 or gamma/delta TCR antigen in 58 SLE patients, investigating the possible role of these cell s ubsets involved in non-MHC-restricted cytotoxicity and their relationship w ith the main clinical and laboratory parameters. SLE patients had, with respect to controls, considerably decreased values o f NK cells (P < 0.0004 in percentage and P < 0.00004 as absolute number), o f non-MHC-restricted T cytotoxic lymphocytes (P < 0.007 and P < 0.0015, res pectively) and of T cells expressing gamma/delta TCR (P < 0.02 and P < 0.00 4, respectively). The absolute numbers of these cell subsets positively cor related to each other (P < 0.009). gamma/delta T cells inversely correlated with higher ESR values, both percentually (P < 0.006; r = -0.367) and in a bsolute number (P < 0.009; r = -0.350). Moreover, the percentage values of this cell subset inversely correlated with higher levels of CRP (P < 0.05; r = -0.256) while SLE patients with anti-SSB/La antibodies had lower values of T lymphocytes bearing gamma/delta TCR, both as percentage (P < 0.008) a nd as absolute number (P < 0.02). Our study indicates that non-MHC-restricted cytotoxicity, shared by NK, NK- like and gamma/delta T cells, may be down-regulated in SLE patients, owing to a significant reduction of these PBMC subsets. These specific cell subse t impairments seem to affect only some aspects of the disease, suggesting a weakening of the regulatory properties of these cells in the control of di fferent immunological and inflammatory features of SLE, that could be of im portance in its clinical expression.